Working Groups

Setting Standards in Vaccine Safety

Your location: Home » Working Groups

Working Groups

Working Group Member Selection and Process

Reference Groups

Working Groups

View Ongoing and Closed Working Groups

Download Published Case Definition & Guidelines Documents of the Working Groups

Status of Case Definitions and Guidelines of Working Groups


Topic		Coordinators	Member Selection	Status of Document
				Initial draft	In Revision	Finalized
Document development started in 2007
1	International Implementation	Barbara Rath	Complete
2	Diarrhea	Jane Gidudu	Complete
3	Bells Palsy	Barbara Rath	Complete
Document development started in 2006
Document development started in 2005
4	Guillain-Barré Syndrome	James Sejvar, Katrin Kohl	Complete
5	A Local Reaction	Katrin Kohl, Jane Gidudu	Local Reaction
Document development started in 2004
6	Neonatal Clinical Trials Guidelines	Hans Spiegel, Katrin Kohl, Jane Gidudu	Complete
7	Aseptic Meningitis	Terhi Tapiainen	Complete
Document development started in 2003
8	Anaphylaxis	Jens Rueggeberg	Complete
9	Encephalitis and Accute Disseminated Encephalomyelitis	James Sejvar, Katrin Kohl	Complete
10	Fatiguing Illness Including Chronic Fatigue Syndrome	Jim Jones, Katrin Kohl	Complete
11	Rash	John Beigel, Katrin Kohl	Complete
12	Thrombocytopenia	Jan Bonhoeffer	Complete
13	Sudden Unexplained Death Syndrome Including SIDS	Terhi Tapiainen	Complete
14	Vaccinia Virus AEFI	Phil LaRussa, Phil Graham, Katrin Kohl	Complete
	Eczema Vaccinatum	Patricia Nell, Katrin Kohl	Complete
	Generalized Vaccinia	John Beigel, Katrin Kohl	Complete
	Inadvertent Inoculation	James Oleske, Katrin Kohl	Complete
	Progressive Vaccinia	Patricia Nell, Katrin Kohl	Complete
	Robust Take	Phil LaRussa, Katrin Kohl	Complete
Document development started in 2002
15	Guidelines for Clinical Trials and Other Studies	Jan Bonhoeffer	Complete
16	General Guidelines for Surveillance Systems	Jan Bonhoeffer	Complete
17	Local Reactions	Katrin Kohl	Complete
	Abscess	Leslie Ball, Katrin Kohl	Complete
	Cellulitis	Scott Halperin, Katrin Kohl	Complete
	Induration	Wikke Walop, Katrin Kohl	Complete
	Swelling	Wikke Walop, Katrin Kohl	Complete
18	Persistent Crying	Jan Bonhoeffer	Complete
19	Generalized Convulsive Seizure	Jan Bonhoeffer	Complete
Document Development Started in 2001
20	Hypotonic-Hyporesponsive Episode	Jan Bonhoeffer	Complete
21	Fever	Katrin Kohl	Complete
22	Intussusception	Katrin Kohl	Complete
23	Nodule at Injection Site	Katrin Kohl	Local Reaction

Currently there are no draft definitions and guidelines open for for review and comment. However, if you would like to complete a web-based survey for any of the upcoming draft definitions, please e-mail: secretariat@brightoncollaboration.org.

The progress of the Working Groups is symbolized in the following way:

Initial draft: Development phase - A draft document is being developed within the respective Working Group

In revision: Comment and review phase - Comments are being received by Reference Group participants via web-based surveys and as appropriate also by the CIOMS/WHO Vaccine Pharmacovigilance Working Group and integrated by the respective Working Group into the document.

Finalized: Editing phase - Final drafts are being harmonized with other Brighton documents, submitted for clearance in the respective organizations of Working Group members, and prepared for submission to a journal.

Progress of Working Groups (last update): January 16th, 2008

> back to top